| Sleep medicine and COVID-19. Has a new era begun? A Voulgaris, L Ferini-Strambi, P Steiropoulos Sleep medicine 73, 170-176, 2020 | 53 | 2020 |
| The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer–a multicentre observational study S Khadhouri, KM Gallagher, KR MacKenzie, TT Shah, C Gao, S Moore, ... BJU international 128 (4), 440-450, 2021 | 44 | 2021 |
| Chronic kidney disease in patients with obstructive sleep apnea. A narrative review A Voulgaris, O Marrone, MR Bonsignore, P Steiropoulos Sleep Medicine Reviews 47, 74-89, 2019 | 42 | 2019 |
| Respiratory involvement in patients with neuromuscular diseases: a narrative review A Voulgaris, M Antoniadou, M Agrafiotis, P Steiropoulos Pulmonary Medicine 2019 (1), 2734054, 2019 | 40 | 2019 |
| Mean platelet volume and platelet distribution width in patients with obstructive sleep apnea syndrome and concurrent chronic obstructive pulmonary disease K Archontogeorgis, A Voulgaris, N Papanas, E Nena, M Froudarakis, ... Clinical and Applied Thrombosis/Hemostasis 24 (8), 1216-1222, 2018 | 29 | 2018 |
| Vitamin D levels in middle-aged patients with obstructive sleep apnoea syndrome K Archontogeorgis, E Nena, N Papanas, A Zissimopoulos, A Voulgaris, ... Current Vascular Pharmacology 16 (3), 289-297, 2018 | 29 | 2018 |
| Cardiovascular risk assessment in a cohort of newly diagnosed patients with obstructive sleep apnea syndrome K Archontogeorgis, A Voulgaris, E Nena, M Strempela, P Karailidou, ... Cardiology Research and Practice 2018 (1), 6572785, 2018 | 29 | 2018 |
| Cardiovascular disease in patients with chronic obstructive pulmonary disease, obstructive sleep apnoea syndrome and overlap syndrome A Voulgaris, K Archontogeorgis, P Steiropoulos, N Papanas Current vascular pharmacology 19 (3), 285-300, 2021 | 28 | 2021 |
| Cystatin C Levels in Middle‐Aged Patients with Obstructive Sleep Apnea Syndrome K Archontogeorgis, E Nena, C Tsigalou, A Voulgaris, M Xanthoudaki, ... Pulmonary Medicine 2016 (1), 8081723, 2016 | 26 | 2016 |
| Effect of periodontal therapy on COPD outcomes: a systematic review I Apessos, A Voulgaris, M Agrafiotis, D Andreadis, P Steiropoulos BMC Pulmonary Medicine 21, 1-16, 2021 | 25 | 2021 |
| Increased risk for cardiovascular disease in patients with obstructive sleep apnoea syndrome‐chronic obstructive pulmonary disease (overlap syndrome) A Voulgaris, K Archontogeorgis, N Papanas, E Pilitsi, E Nena, ... The Clinical Respiratory Journal 13 (11), 708-715, 2019 | 22 | 2019 |
| Serum levels of NGAL and cystatin C as markers of early kidney dysfunction in patients with obstructive sleep apnea syndrome A Voulgaris, K Archontogeorgis, E Nena, C Tsigalou, M Xanthoudaki, ... Sleep and Breathing 23, 161-169, 2019 | 20 | 2019 |
| Metabolic syndrome and vitamin D levels in patients with obstructive sleep apnea syndrome K Archontogeorgis, E Nena, N Papanas, M Rizzo, A Voulgaris, ... Metabolic Syndrome and Related Disorders 16 (4), 190-196, 2018 | 20 | 2018 |
| Developing a diagnostic multivariable prediction model for urinary tract cancer in patients referred with haematuria: results from the IDENTIFY collaborative study S Khadhouri, KM Gallagher, KR MacKenzie, TT Shah, C Gao, S Moore, ... European Urology Focus 8 (6), 1673-1682, 2022 | 17 | 2022 |
| Burden of comorbidities in patients with OSAS and COPD-OSAS overlap syndrome A Voulgaris, K Archontogeorgis, A Pataka, AN Flaris, P Ntolios, ... Medicina 57 (11), 1201, 2021 | 17 | 2021 |
| Insulin sensitivity and insulin resistance in non-diabetic middle-aged patients with obstructive sleep apnoea syndrome K Archontogeorgis, N Papanas, E Nena, A Tzouvelekis, C Tsigalou, ... The Open Cardiovascular Medicine Journal 11, 159, 2017 | 13 | 2017 |
| Reduced serum vitamin D levels are associated with insulin resistance in patients with obstructive sleep apnea syndrome K Archontogeorgis, N Papanas, EC Rizos, E Nena, A Zissimopoulos, ... Medicina 55 (5), 174, 2019 | 11 | 2019 |
| Effect of compliance to continuous positive airway pressure on exacerbations, lung function and symptoms in patients with chronic obstructive pulmonary disease and obstructive … A Voulgaris, K Archontogeorgis, S Anevlavis, M Fanaridis, ... The Clinical Respiratory Journal 17 (3), 165-175, 2023 | 10 | 2023 |
| Comment on: Comorbidities in coexisting chronic obstructive pulmonary disease and obstructive sleep apnea-overlap syndrome. A Voulgaris, E Nena, P Steiropoulos European Review for Medical and Pharmacological Sciences 22 (19), 6171-6172, 2018 | 9 | 2018 |
| Is kidney a new organ target in patients with obstructive sleep apnea? Research priorities in a rapidly evolving field A Voulgaris, MR Bonsignore, S Schiza, O Marrone, P Steiropoulos Sleep medicine 86, 56-67, 2021 | 8 | 2021 |
